The global prevalence of non-alcoholic fatty liver disease (NAFLD) is 25%. It is considered to be endemic in Europe and a major potential threat to public health. Yet it appears to receive very limited attention. EASL International Liver Foundation aims to place the spotlight on NALFD and take the first important step needed to generate a call to action by developing an understanding of what government and key stakeholders such as medical associations and patient groups are currently doing.

The NASH-CORE study, led by Professor Jeffrey Lazarus, will systematically review the relevant policies European countries have in place to address NAFLD and non-alcoholic steatohepatitis (NASH), the most serious form of NAFLD.

The results of NASH-CORE will be presented in conjunction with the First EASL NAFLD summit, which is being held in Rome, 9-11 November, 2017.